SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049159
Filing Date
2024-04-26
Accepted
2024-04-26 16:16:07
Documents
9
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A scph-def14a-2024_-_proxy.htm DEF 14A 941392
2 GRAPHIC img245999468_0.jpg GRAPHIC 13834
3 GRAPHIC img245999468_1.jpg GRAPHIC 33852
4 GRAPHIC img245999468_2.jpg GRAPHIC 18936
5 GRAPHIC img245999468_3.jpg GRAPHIC 18936
6 GRAPHIC img245999468_4.jpg GRAPHIC 184679
7 GRAPHIC img245999468_5.jpg GRAPHIC 33401
8 GRAPHIC img245999468_6.jpg GRAPHIC 718401
9 GRAPHIC img245999468_7.jpg GRAPHIC 178693
  Complete submission text file 0000950170-24-049159.txt   2590402
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38293 | Film No.: 24883991
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)